The Drugs Controller General of India (DGCI) has granted restricted emergency use authorization to Bharat Biotech’s Covaxin for children aged 6 to 12 years on Tuesday. The panel had approved Covaxin for emergency use in children above 12 years in December 2021.
On vaccination of 6-12 year-olds, the company has been asked to submit safety data, including that on adverse events, with due analysis every 15 days for the first two months and monthly thereafter for five months.